Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Wire Cambodia.
Press releases published on April 15, 2025
IPG Photonics to Announce First Quarter 2025 Financial Results on May 6
GlobeNewswire
·
April 15, 2025
MARLBOROUGH, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its first quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. The Company will hold a conference call to review these …
Rezolve Ai Secures $9.8 Million Annual Contract with Liverpool Mexico
GlobeNewswire
·
April 15, 2025
NEW YORK and MEXICO CITY, April 15, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce technology, is proud to announce a landmark $9.8 million yearly contract with Liverpool Mexico, the country’s premier department …
ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
GlobeNewswire
·
April 15, 2025
In combination with atezolizumab or durvalumab Study conducted under the CRADA agreement between NCI and Oryzon MADRID and CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage …
Pipe Acquires Glean.ai to Add Spend Management to Suite of Embedded Financial Solutions
GlobeNewswire
·
April 15, 2025
SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Pipe, a fintech company enabling embedded financial solutions for software platforms, today announced its strategic acquisition of Glean.ai, a leading AI-powered spend management company. With this …
Mural Oncology Announces Plans to Explore Strategic Alternatives
GlobeNewswire
·
April 15, 2025
Following review of data from the phase 2 ARTISTRY-6 trial and previously announced results from the phase 3 ARTISTRY-7 trial, Mural will discontinue all clinical development of nemvaleukin With $144.4 million in cash as of December 31, 2024, Mural plans …
LyondellBasell avança na liderança em sustentabilidade no Relatório de Sustentabilidade de 2024: Da Visão ao Valor
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- A LyondellBasell (NYSE: LYB), líder global na indústria química, divulgou hoje seu Relatório de Sustentabilidade de 2024, demonstrando progresso significativo em soluções circulares e de baixo carbono, ação …
LyondellBasell rafforza la leadership in materia di sostenibilità con il suo Rapporto di Sostenibilità 2024: “From Vision to Value”
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), leader globale nell'industria chimica, ha pubblicato oggi il suo Rapporto sulla Sostenibilità 2024, confermando progressi significativi nell’ambito delle soluzioni circolari e a basse …
zSpace Acquires Second Avenue Learning to Revolutionize Experiential Education
GlobeNewswire
·
April 15, 2025
SAN JOSE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc., a leading provider of augmented and virtual reality (AR/VR) solutions for education, proudly announces the acquisition of Second Avenue Learning, a Rochester, NY-based innovator in …
AgEagle Showcases eBee VISION Drone at 173rd Airborne Brigade Innovation Symposium
GlobeNewswire
·
April 15, 2025
Private event featured demonstrations and roundtable discussions with key members of the armed forces and key decision makers WICHITA, Kan., April 15, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS) (“AgEagle” or the “Company”), a leading …
Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
GlobeNewswire
·
April 15, 2025
WARRINGTON, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported …
TransGlobal Assets Inc. (OTC: TMSH) and The Now Corporation (OTC: NWPN) Strike Strategic Deal to Commercialize Acclaimed Works by Michael Berman
GlobeNewswire
·
April 15, 2025
Strategic IP Partnership Expands Literary Works into Multimedia: TransGlobal Assets Inc. (OTC: TMSH), through Mindwell Solutions Group, has signed an exclusive global media rights deal with The Now Corporation (OTC: NWPN) to adapt and commercialize the …
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
GlobeNewswire
·
April 15, 2025
All proposals of Board of Directors approved Gilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for re-election confirmed Dividend of CHF 0.60 per registered dividend-paying share approved, representing 24% of …
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
GlobeNewswire
·
April 15, 2025
REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in highly prevalent ocular diseases, today reported financial …
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
GlobeNewswire
·
April 15, 2025
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug …
Zions Bancorporation to Implement nCino Platform and Intelligent Solutions as the Technology Foundation of its Lending End-to-End Process Transformation
GlobeNewswire
·
April 15, 2025
WILMINGTON, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced that Zions Bancorporation has selected nCino as its technology platform as they digitally …
Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments
GlobeNewswire
·
April 15, 2025
- Vikram Ranade, PhD, appointed as chief business officer - - Ranjan Batra, PhD, appointed as chief scientific officer - - Oxana Beskrovnaya, PhD, transitioning to chief innovation officer - WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Dyne …
Mawson Infrastructure Group Inc. Announces Participation in Upcoming Conferences and Events
GlobeNewswire
·
April 15, 2025
MIDLAND, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) ("Mawson" or "the Company"), a publicly-traded technology company focused on digital infrastructure platforms for artificial intelligence (AI), high- …
Repligen to Report First Quarter 2025 Financial Results
GlobeNewswire
·
April 15, 2025
WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2025 financial results on Tuesday, April 29, 2025. The Company will issue a press release before the market …
A quarter of Gen Z now pays for social media
GlobeNewswire
·
April 15, 2025
SAN JOSE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- In a surprising twist to the once-free world of social media, nearly a quarter (23%) of Gen Z Americans (aged 18-25) now pay for a subscription to social media platforms such as Snapchat and X. That’s …
Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …